Pharmacological treatment and management of attention deficit hyperactivity disorder (ADHD) in adults.

S Pallanti, L Salerno - Minerva Psichiatrica, 2013 - psycnet.apa.org
Aim: Attention deficit hyperactivity disorder (ADHD) in adulthood has been studied
extensively in recent years. ADHD prevalence and persistence over the lifespan have been …

Pharmacotherapy of attention deficit hyperactivity disorder in adults

TE Wilens, J Biederman, TJ Spencer - CNS drugs, 1998 - Springer
Attention deficit hyperactivity disorder (ADHD) in adults is an increasingly recognised
condition that is associated with substantial functional impairment. Adults with ADHD …

Background, clinical features and treatment of attention deficit hyperactivity disorder in children

N Warikoo, SV Faraone - Expert opinion on pharmacotherapy, 2013 - Taylor & Francis
Introduction: Attention deficit hyperactivity disorder (ADHD) is an early onset, clinically
heterogeneous, complex neurobiological disorder, defined by symptoms of inattention and …

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges

M Mosheva, N Dar, LR Madi, A Weizman… - International Clinical …, 2020 - journals.lww.com
Multiple studies have shown that pharmacologic treatments for attention-deficit hyperactivity
disorder (ADHD), especially stimulants, are generally effective. There is yet a paucity of …

The evidence-based pharmacological treatment of paediatric ADHD

BS Vaughan, JS March… - International Journal of …, 2012 - academic.oup.com
Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and
adults, with extensive research establishing it as a valid neurobiological disorder. Without …

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association …

B Bolea-Alamañac, DJ Nutt… - Journal of …, 2014 - journals.sagepub.com
Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal
burden. The present guidelines summarise current literature, generating expert consensus …

Pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD) in adults

JH Dowson - Current Psychiatry Reviews, 2006 - ingentaconnect.com
Attention-Deficit/Hyperactivity Disorder (ADHD), as defined by DSM-IV, is a heterogeneous
syndrome affecting an estimated 7% of children. Many will continue to have clinically …

[HTML][HTML] Evidence-based pharmacological treatment options for ADHD in children and adolescents

K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2022 - Elsevier
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …

Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies

AC Shier, T Reichenbacher… - Journal of central …, 2013 - journals.sagepub.com
Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of
childhood that can result in significant functional impairment, and if not adequately treated …

Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder

JP Horrigan - Expert Opinion on Pharmacotherapy, 2001 - Taylor & Francis
Attention deficit/hyperactivity disorder (ADHD) is often a lifelong condition. When untreated
or undertreated, it appears to have a deleterious impact upon the daily functioning of the …